Detalhe da pesquisa
1.
Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model.
Biol Blood Marrow Transplant
; 25(11): 2243-2250, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31284070
2.
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Biol Blood Marrow Transplant
; 25(4): 699-711, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30423480
3.
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Haematologica
; 104(4): 844-854, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30381298
4.
Donor Lymphocyte Infusions Used to Treat Mixed-Chimeric and High-Risk Patient Populations in the Relapsed and Nonrelapsed Settings after Allogeneic Transplantation for Hematologic Malignancies Are Associated with High Five-Year Survival if Persistent Full Donor Chimerism Is Obtained or Maintained.
Biol Blood Marrow Transplant
; 23(11): 1989-1997, 2017 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-28712934
5.
Impact of Public Reporting of Center-Specific Survival Analysis Scores on Patient Volumes at Hematopoietic Cell Transplant Centers.
Transplant Cell Ther
; 29(8): 523-528, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37220838
6.
Clinical roundtable monograph: Unmet needs in the management of chronic myelogenous leukemia.
Clin Adv Hematol Oncol
; 10(12 Suppl 22): 1-16, 2012 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-23271195
7.
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid Leukemia.
J Clin Oncol
; 39(29): 3261-3272, 2021 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-34156898
8.
Transportation of peripheral blood progenitor cell products: effect of ambient temperature.
Cytotherapy
; 12(7): 919-23, 2010 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-20429789
9.
Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentration.
Cytotherapy
; 11(1): 79-85, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19153854
10.
Starting granulocyte-colony-stimulating factor (filgrastim) early after autologous peripheral blood progenitor cell transplantation leads to faster engraftment without increased resource utilization.
Transfusion
; 49(3): 548-54, 2009 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-19040494
11.
Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
Br J Haematol
; 141(1): 80-3, 2008 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-18324970
12.
Second-generation BCR-ABL kinase inhibitors in CML.
N Engl J Med
; 363(17): 1672-3; author reply 1673-5, 2010 10 21.
Artigo
Inglês
| MEDLINE | ID: mdl-20973144
13.
Improving Outcomes in Chronic Myeloid Leukemia Over Time in the Era of Tyrosine Kinase Inhibitors.
Clin Lymphoma Myeloma Leuk
; 18(11): 710-723, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30093283
14.
Exploratory study on the impact of switching to nilotinib in 18 patients with chronic myeloid leukemia in chronic phase with suboptimal response to imatinib.
Ther Adv Hematol
; 8(1): 3-12, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-28042454
15.
Considering baseline factors and early response rates to optimize therapy for chronic myeloid leukemia in chronic phase.
Leuk Lymphoma
; 57(5): 1002-14, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26726949
16.
Rationale and motivating factors for treatment-free remission in chronic myeloid leukemia.
Leuk Lymphoma
; 57(12): 2739-2751, 2016 12.
Artigo
Inglês
| MEDLINE | ID: mdl-27562641
17.
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH Study.
Clin Lymphoma Myeloma Leuk
; 16(5): 286-96, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-26993758
18.
Barriers to physician adherence to evidence-based monitoring guidelines in chronic myelogenous leukemia.
J Oncol Pract
; 11(3): e398-404, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25758446
19.
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy study.
Arch Pathol Lab Med
; 138(9): 1186-92, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24308645
20.
Translating trial-based molecular monitoring into clinical practice: importance of international standards and practical considerations for community practitioners.
Clin Lymphoma Myeloma Leuk
; 11(5): 385-95, 2011 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-21723805